Transforming BioPharma AIfrom Experimentationto Execution
A curated half-day AI Acceleration Forum showcasing how Kedrion and InstaLILY are operationalizing AI responsibly and at scale.
Partners Driving the Summit
The BioPharma industry is crowded with AI “experiments” that never leave the lab. While others are stuck in pilot purgatory, we are focusing on acceleration.
The Kedrion x InstaLILY AI and Innovation Summit is a curated, half-day intensive designed to dismantle the barriers between AI strategy and enterprise-wide execution. This isn't a theoretical look at the future, it is a roadmap for how Kedrion and InstaLILY are operationalizing AI responsibly, at scale, right now.
The partnership between Kedrion and InstaLILY represents the frontier of BioPharma. By combining deep industry expertise with rapid execution, we are moving past the “hype cycle” to build AI systems that actually work within the rigors of regulated environments.
Voices Shaping the Summit
As part of NYC Tech Week, Kedrion and InstaLILY AI have curated a half-day AI and Innovation Summit designed to move the BioPharma industry from experimentation to execution.
The Kedrion x InstaLILY AI & Innovation Summit will showcase how artificial intelligence is operationalized responsibly, at scale, and inside real-world systems.
Paige Bailey
AI Developer Experience Engineer
Olivia Howard
Partner
Crissy Costa Behrens
Managing Director
Peter Michel
Managing Director
Omer Awan
Vice President
Bob Rossilli
Chief Commercial Officer, Global Business
Dmitry Simkhovich
Global Head of Business Intelligence
Amit Shah
Founder & CEO
Sumantro Das
Co-Founder & COO
Matt Ridenour
Head of Startups
Andrea Caricasole
Chief Research and Innovation Officer
Nithya Sabanayagam Grande
Business Transformation Executive
Duccio Manetti
Chief Communications & Government Affairs Officer
Brett Dethmers
CFO
Jason J. Leavy
Director, Global Supply Chain – Data Science
Ashley Knapp
Co-Founder & Chief Development Officer
Jason Weems
Chief Information Officer
Anthony Mariello
VP, Head of Brand
Gino Matteoni
IT Application Manager, BI & Artificial Intelligence
Gionni Bernardini
Vice President Global Information Technology
Opening & Registration
Start the day with registration, and networking with Biopharma and AI leaders.
The AI Inflection Point: A State of the Industry
Healthcare is entering a new era of transformation, where advances in technology, science, and data are reshaping the industry and redefining what leadership will require to navigate and capitalize on the opportunities ahead.
AI in Action: The Augmentation Engine, Live
Meet InstaSales—an AI-powered platform that turns data into action. See how it identifies opportunities, prioritizes accounts, and delivers personalized next best actions, route plans, and actionable insights to help sales teams focus on what matters most.
How Innovation Actually Happens
Three operators: from commercial intelligence, supply and business transformation, talk about what it looks like to deploy AI inside complex, regulated environments.
The Frontier: What Today's Most Powerful AI Can Actually Do
A demonstration from the cutting edge of AI development. See what frontier models can do right now — and what it means for the future of science, drug discovery, and human health.
Networking Break
From Molecule to Mind: The Next Frontier of Intelligence in Healthcare
From drug discovery to clinical development, AI is changing how science gets done. Explore how researchers are combining deep domain expertise with emerging technologies to unlock new possibilities.
Brand Activation in AI
What does brand authenticity look like when AI can generate everything? A discussion about the opportunities, risks, and new rules of marketing and communications in the AI era.
The Case for Synthetic Data
When real-world data is scarce, waiting isn't the answer. Take a look at how synthetic data trains more robust ML models and has potential in clinical trials with limited patient populations.
Capital, Conviction, and Compounding Value
How the sharpest investors think about AI-native companies: what signals conviction, what drives compounding advantage, and where the next wave of value will be built in biopharma.
Specialty Pharmacy and AIC Panel Discussion
What it actually takes to implement AI and drive innovation in specialty pharmacy—where it creates real impact across patient access, operations, and outcomes, and what we've learned along the way.